Related Experiment Video
Updated: May 5, 2026
Mass Histology to Quantify Neurodegeneration in Drosophila
Published on: December 15, 2016
Drosophila melanogaster as a model organism for Alzheimer's disease
Katja Prüßing1, Aaron Voigt, Jörg B Schulz
1Department of Neurology, University Medical Center, RWTH Aachen, Pauwelsstrasse 30, D-52074 Aachen, Germany. avoigt@ukaachen.de.
Abstract:
Drosophila melanogaster provides an important resource for in vivo modifier screens of neurodegenerative diseases. To study the underlying pathogenesis of Alzheimer's disease, fly models that address Tau or amyloid toxicity have been developed. Overexpression of human wild-type or mutant Tau causes age-dependent neurodegeneration, axonal transport defects and early death. Large-scale screens utilizing a neurodegenerative phenotype induced by eye-specific overexpression of human Tau have identified several kinases and phosphatases, apoptotic regulators and cytoskeleton proteins as determinants of Tau toxicity in vivo. The APP ortholog of Drosophila (dAPPl) shares the characteristic domains with vertebrate APP family members, but does not contain the human Aβ42 domain. To circumvent this drawback, researches have developed strategies by either direct secretion of human Aβ42 or triple transgenic flies expressing human APP, β-secretase and Drosophila γ-secretase presenilin (dPsn). Here, we provide a brief overview of how fly models of AD have contributed to our knowledge of the pathomechanisms of disease.
Insights
Fruit fly models are crucial for studying Alzheimer's disease (AD) mechanisms. Researchers use these models to investigate Tau and amyloid toxicity, advancing our understanding of neurodegeneration.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Drosophila melanogaster serves as a valuable model organism for in vivo genetic screens.
- Alzheimer's disease (AD) pathogenesis is studied using fly models that mimic Tau or amyloid toxicity.
- Overexpression of human Tau in flies induces age-dependent neurodegeneration and axonal transport defects.
Purpose of the Study:
- To provide an overview of how Drosophila models contribute to understanding Alzheimer's disease.
- To highlight the utility of fly models in identifying genetic modifiers of neurodegenerative disease.
Main Methods:
- Development of Drosophila models for Tau toxicity via eye-specific overexpression.
- Utilizing large-scale screens to identify Tau toxicity determinants.
- Engineering fly models for amyloid precursor protein (APP) and Aβ42 toxicity.
Main Results:
- Identification of kinases, phosphatases, apoptotic regulators, and cytoskeleton proteins affecting Tau toxicity.
- Development of strategies to model human Aβ42 toxicity in flies.
- Demonstration of Tau-induced neurodegeneration and shortened lifespan in Drosophila.
Conclusions:
- Drosophila models are powerful tools for dissecting the complex pathomechanisms of Alzheimer's disease.
- Fly-based screens have successfully identified key genetic players in Tau-mediated neurotoxicity.
- Advances in fly genetics enable the study of both Tau and amyloid pathologies relevant to AD.
More Related Videos
10:13Dissection and Immunofluorescent Staining of Mushroom Body and Photoreceptor Neurons in Adult Drosophila melanogaster Brains
Published on: November 6, 2017
09:17Assessing Neurodegenerative Phenotypes in Drosophila Dopaminergic Neurons by Climbing Assays and Whole Brain Immunostaining
Published on: April 24, 2013